在治疗,价格和证据不断变化的背景下,使用成本效益分析支持新药定价和报销决策的框架
Beth Woods1, Alfredo Palacios2, Mark Sculpher2
1Centre for Health Economics, University of York, York, UK. beth.woods@york.ac.uk.
PharmacoEconomics
|December 31, 2024
概括
目前的制药定价和融资模式往往是一次性的决定. 一个使用成本效益分析的新框架支持动态定价和资金用于不断发展的多比较药物指示,以使资源配置与人口健康目标保持一致.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 决策分析 决策分析
背景情况:
- 目前的制药定价和融资往往依赖于静态的,单一指示的决定.
- 随着治疗,证据和价格的发展,这可能导致资源分配不足.
- 缺乏明确的优先级框架阻碍了卫生系统管理多种治疗选择.
研究的目的:
- 提出一个新的药品定价和资金的框架,用于多类比较指标.
- 将成本效益分析 (CEA) 整合到动态定价和融资政策中.
- 解决不断变化的证据,药品价格和临床选择的复杂性.
主要方法:
- 制定一个有三个核心考虑的框架:适当的流程,评估多种治疗选择,并应用CEA决策规则.
- 优先考虑与明确目标一致的重新评估主题,并允许灵活的决策.
- 探索合同重新规范和医疗技术评估 (HTA) 流程.
- 分析推多种治疗方案的理由和权衡.
- 调查基于价值的定价策略与保密折扣.
主要成果:
- 建议制药定价和融资的动态框架,适应不断变化的市场条件.
- 强调重新评估的比例流程和灵活的决策.
- 强调推多种治疗选择的潜在好处和权衡.
- 建议在竞争性市场实现基于价值的定价机制.
结论:
- 基于CEA的动态框架对于使药品定价和资金与人口健康目标保持一致至关重要.
- 卫生技术评估机构必须明确解决与推多种治疗方法相关的权衡问题.
- 灵活和比例的流程对于在不断变化的制药市场中有效分配资源至关重要.
相关概念视频
01:12Analysis of Population Pharmacokinetic Data
224
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
224
01:16Bioequivalence: Overview
921
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
921
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
01:03Drug Control Governance: Regulatory Bodies and Their Impact
141
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
141
01:11Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
01:28Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K